| Gene symbol | tk |
| GTO ID | GTC0055 |
| Trial ID | NCT00638612 |
| Disease | Pancreatic Cancer |
| Altered gene | tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | AdV-tk |
| Co-treatment | Valacyclovir |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer |
| Year | 2008 |
| Country | United States |
| Company sponsor | Candel Therapeutics, Inc. |
| Other ID(s) | PaTK01 |
| Vector information | |||||||||||
|
|||||||||||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||